Login / Signup

Is the BNT162b2 COVID-19 vaccine effective in elderly populations? Results from population data from Bavaria, Germany.

Delphina GomesAndreas BeyerleinKatharina KatzGabriele HoelscherUta NennstielBernhard LieblKlaus ÜberlaRuediger Von Kries
Published in: PloS one (2021)
Two doses of BioNTech-Pfizer's BNT162b2 vaccine is highly effective against COVID-19 outcomes in elderly persons.
Keyphrases
  • coronavirus disease
  • sars cov
  • middle aged
  • community dwelling
  • respiratory syndrome coronavirus
  • big data
  • type diabetes
  • machine learning
  • adipose tissue
  • artificial intelligence
  • genetic diversity
  • weight loss